JAMES LAMB: Open Payments
NPI 1316655178 · LEBANON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 38 payments from 15 companies in 2025. Trend: 2023 $640 · 2024 $1,160 · 2025 $682
Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Alkermes, Inc. | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 3 | $54 |
| AngioDynamics, Inc. | 3 | $50 |
| Noven Therapeutics, LLC | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| PFIZER INC. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Qelbree, Secuado, VIVITROL, Auvelity, ALPHAVAC.
Industry payments across IN — which companies pay providers there.
